Brief: Orexo Initiates Feasibility Studies Of Amorphox

Orexo AB

09/01/2023 07:06

Jan 9 (Reuters) - Orexo AB  ORX.ST :
    * OREXO INITIATES EXPLORATORY FEASIBILITY STUDIES OF
AMORPHOX ® 
WITH TWO LEADING BIOPHARMACEUTICAL AND VACCINE COMPANIES
    * FEASIBILITY STUDIES FOLLOW SUCCESSFUL FORMULATION OF
COVID-19
SPIKE PROTEIN IN AMORPHOX

Source text for Eikon:  ID:nWkrbfZ7hp 
Further company coverage:  ORX.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))